 |
|
Methadone Maintenance in Primary Care
A Randomized Controlled Trial
David A. Fiellin, MD;
Patrick G. O'Connor, MD,MPH;
Marek Chawarski, PhD;
Juliana P. Pakes, MEd;
Michael V. Pantalon, PhD;
Richard S. Schottenfeld, MD
JAMA. 2001;286:1724-1731.
Context Methadone maintenance is an effective treatment for opioid dependence, yet its use is restricted to federally licensed narcotic treatment programs (NTPs). Office-based care of stabilized methadone maintenance patients is a promising alternative but no data are available from controlled trials regarding this type of program.
Objective To determine the feasibility and efficacy of office-based methadone maintenance by primary care physicians vs in an NTP for stable opioid-dependent patients.
Design Six-month, randomized controlled open clinical trial conducted February 1999-March 2000.
Setting Offices of 6 primary care internists and an NTP.
Patients Forty-seven opioid-dependent patients who had been receiving methadone maintenance therapy in an NTP without evidence of illicit drug use for 1 year and without significant untreated psychiatric comorbidity were randomized; 1 patient refused to participate after treatment assignment to NTP.
Interventions Patients were randomly assigned to receive office-based methadone maintenance from primary care physicians, who received specialized training in the care of opioid-dependent patients (n = 22), or usual care at an NTP (n = 24).
Main Outcome Measures Illicit drug use, clinical instability (persistent drug use), patient and clinician satisfaction, functional status, and use of health, legal, and social services, compared between the 2 groups.
Results Eleven of 22 (50%; 95% confidence interval [CI], 29%-71%) patients in office-based care compared with 9 of 24 (38%; 95% CI, 21%-57%) of NTP patients had a self-report or urine toxicology test result indicating illicit opiate use (P = .39). Hair toxicology testing detected an additional 2 patients in each treatment group with evidence of illicit drug use, but this did not change the overall findings. Ongoing illicit drug use meeting criteria for clinical instability occurred in 4 of 22 (18%; 95% CI, 7%-39%) patients in office-based care compared with 5 of 24 (21%; 95% CI, 9%-41%) NTP patients (P = .82). Sixteen of the 22 (73%; 95% CI, 54%-92%) office-based patients compared with 3 of the 24 (13%; 95% CI, 0%-26%) NTP patients thought the quality of care was excellent (P = .001). There were no differences over time within or between groups in functional status or use of health, legal, or social services.
Conclusions Our results support the feasibility and efficacy of transferring stable opioid-dependent patients receiving methadone maintenance to primary care physicians' offices for continuing treatment and suggest guidelines for identifying patients and clinical monitoring.
Author Affiliations: Departments of Internal Medicine (Drs Fiellin and O'Connor) and Psychiatry (Drs Chawarski, Pantalon, and Schottenfeld), Yale University School of Medicine, New Haven, Conn; and the Department of Health Care Policy, Harvard Medical School, Boston, Mass (Ms Pakes).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED ARTICLES
Integrating Primary Medical Care With Addiction Treatment: A Randomized Controlled Trial
Constance Weisner, Jennifer Mertens, Sujaya Parthasarathy, Charles Moore, and Yun Lu
JAMA. 2001;286(14):1715-1723.
ABSTRACT
| FULL TEXT
Generalist Physicians and Addiction Care: From Turfing to Sharing the Turf
Michael D. Stein and Peter D. Friedmann
JAMA. 2001;286(14):1764-1765.
EXTRACT
| FULL TEXT
October 10, 2001
JAMA. 2001;286(14):1779-1780.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Pharmacist Influence in Buprenorphine Treatment Outcomes for Opioid Dependence
Tomko and Giannetti
The Annals of Pharmacotherapy 2007;41:161-161.
FULL TEXT
Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
Fiellin et al.
NEJM 2006;355:365-374.
ABSTRACT
| FULL TEXT
Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy
Lucas et al.
Am J Epidemiol 2006;163:412-420.
ABSTRACT
| FULL TEXT
Barriers and Facilitators to Primary Care or Human Immunodeficiency Virus Clinics Providing Methadone or Buprenorphine for the Management of Opioid Dependence
Turner et al.
Arch Intern Med 2005;165:1769-1776.
ABSTRACT
| FULL TEXT
Dose-Related Distribution of Codeine, Cocaine, and Metabolites into Human Hair following Controlled Oral Codeine and Subcutaneous Cocaine Administration
Scheidweiler et al.
J. Pharmacol. Exp. Ther. 2005;313:909-915.
ABSTRACT
| FULL TEXT
Factors Associated With Illegal Drug Use Among Older Methadone Clients
Rosen
Gerontologist 2004;44:543-547.
ABSTRACT
| FULL TEXT
Medical and Psychiatric Conditions of Alcohol and Drug Treatment Patients in an HMO: Comparison With Matched Controls
Mertens et al.
Arch Intern Med 2003;163:2511-2517.
ABSTRACT
| FULL TEXT
Evidence-Based Treatments for Substance Use Disorders
Gold and Brady
Focus 2003;1:115-122.
ABSTRACT
| FULL TEXT
HIV and the Law: Integrating Law, Policy, and Social Epidemiology
Lazzarini and Klitzman
J Law Med Ethics 2002;30:533-547.
New Federal Initiatives To Enhance the Medical Treatment of Opioid Dependence
Fiellin and O'Connor
ANN INTERN MED 2002;137:688-692.
ABSTRACT
| FULL TEXT
Office-Based Treatment of Opioid-Dependent Patients
Fiellin and O'Connor
NEJM 2002;347:817-823.
FULL TEXT
Integrating Primary Care and Addiction Care
JWatch Psychiatry 2001;2001:10-10.
FULL TEXT
A 28-Year-Old Man Addicted to Cocaine
Hyman
JAMA 2001;286:2586-2594.
FULL TEXT
Integrating Primary Care and Addiction Care
JWatch General 2001;2001:2-2.
FULL TEXT
Generalist Physicians and Addiction Care: From Turfing to Sharing the Turf
Stein and Friedmann
JAMA 2001;286:1764-1765.
FULL TEXT
|
